T1
Development of concepts and discoveries from basic research through early phase clinical trialsUnder the leadership of Vice Chancellor for Research Thomas Flaig, MD, we work to ensure all campus research is compliant with the highest ethical and intellectual standards. With expertise in contracting, funding, compliance, laboratory protocols, clinical research operations and more, our teams provide comprehensive resources to support investigators through every step of the research lifecycle.
T1
Development of concepts and discoveries from basic research through early phase clinical trialsT2
Establishment of efficacy in humans and clinical guidelinesT3
Implementation and dissemination of phase T2 research resultsT4
Assessment of outcomes and effectiveness of clinical interventions in populationsBENCH
Basic Science
BEDSIDE
Translation to HumansPATIENTS
Translation to PatientsPRACTICE
Translation to PracticePUBLIC HEALTH
Translation to
Populations
Software Change for CDA & MTA Submissions
The Confidential Disclosure Agreements (CDA)/Material Transfer Agreements (MTA) submission process transitions from Formstack to a REDCap.
LEARN MORE
Annual HIPAA Training Deadline
Employees with access to protected health information are required to complete HIPAA training each year.
LEARN MORE
Annual COI Disclosure Period
The Conflict of Interest form is being migrating into new software. Employees must manually enter content into the new form, and the content can be copied over from year to year going forward.
LEARN MORE
#16
HEALTH SCIENCES RESEARCH IN USA
Nature magazine$762M
SPONSORED RESEARCH FUNDING
3,800+
STUDIES SUPPORTED
300+
OVCR EMPLOYEES WHO PARTNER WITH RESEARCHERS
Uptibus quaes ent adias ea enim ipsunt que quasperro cum volut exeruNus, tenisqui diore nemquiae parum sum inite ducita tiunt.